SciSparc Awarded Three Patents For Its Novel Compounds and Methods
Ryan Allway September 7th, 2021 TEL AVIV, Israel, Sept. 7, 2021 /PRNewswire/ — SciSparc Ltd. (OTC Pink: SPRCF), a specialty, clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system (the “Company”), today announced it has been awarded two patents from the Australian Patent... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )